Pemetrexed (Alimta) in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study (LUN04-78)
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2014
At a glance
- Drugs Pemetrexed (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 16 Nov 2007 Status changed from in progress to discontinued (the results from an interim analysis were not favorable to continue this trial).
- 26 Nov 2005 New trial record.